GlassScriptPhysician profile
Abby E Mcmahon
NPI 1811144629
$12,167.71
in general payments reported to CMS, 2019-2025
53 companies · $2,572 in 2025
The $2,572 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,102 · 2022: $1,920 · 2023: $2,300 · 2024: $4,273 · 2025: $2,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,086 · Travel and Lodging: $1,014 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,086.48 |
| Travel and Lodging | $1,013.60 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,468.25 | 2021-2025 | |
| Organogenesis INC. | $1,704.59 | 2024 | Affinity, Novachor, Nushield |
| Novo Nordisk INC | $1,291.91 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $912.28 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $649.47 | 2021-2025 | Otezla, Evenity, Enbrel |
| Lilly USA, LLC | $514.73 | 2021-2025 | Mounjaro, Zepbound, Taltz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $417.81 | 2021-2025 | Jardiance, Cyltezo, Tradjenta |
| Glaxosmithkline, LLC. | $367.33 | 2021-2024 | Trelegy Ellipta, Benlysta, Nucala |
| Ucb, INC. | $287.09 | 2022-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $264.44 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $243.04 | 2023-2025 | Acthar |
| Axsome Therapeutics, INC. | $228.36 | 2022-2025 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $201.27 | 2021-2025 | Trintellix |
| Antares Pharma, INC. | $192.03 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Esperion Therapeutics, INC. | $191.03 | 2023-2025 | Nexletol |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $179.95 | 2021-2024 | Linzess |
| Kowa Pharmaceuticals America, INC. | $169.58 | 2021-2025 | Zoryve, Livalo, Seglentis |
| Exact Sciences Corporation | $156.09 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bausch Health US, LLC | $155.56 | 2022-2023 | Aplenzin |
| Janssen Biotech, INC. | $145.56 | 2022-2025 | Tremfya, Simponi, Remicade |
| Alexion Pharmaceuticals, INC. | $145.36 | 2023-2025 | Strensiq |
| Lundbeck LLC | $126.28 | 2022-2024 | Rexulti |
| Amarin Pharma, INC. | $107.50 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $80.76 | 2021-2023 | Nexletol, Onzetra Xsail, Nexlizet |
| Biohaven Pharmaceutical Holding Company LTD. | $79.25 | 2022 | |
| Halozyme INC | $66.26 | 2023 | |
| Aurinia Pharma U.S., INC. | $62.73 | 2022-2025 | Lupkynis |
| Abbott Laboratories | $55.48 | 2023-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.39 | 2023-2024 | Xifaxan, Cycloset |
| Biohaven Pharmaceuticals, INC. | $53.33 | 2021 | |
| Daiichi Sankyo INC. | $45.76 | 2022-2023 | Injectafer |
| Valinor Pharma, LLC | $44.52 | 2025 | Movantik |
| Janssen Pharmaceuticals, INC | $44.34 | 2022-2024 | Opsumit |
| Horizon Therapeutics Plc | $42.19 | 2022-2023 | Krystexxa |
| Collegium Pharmaceutical, INC. | $37.32 | 2023-2024 | Belbuca |
| Eisai INC. | $33.86 | 2022 | |
| Philips North America LLC | $33.57 | 2024 | (Ak6) Vest Therapy |
| Radius Health, INC. | $24.07 | 2025 | Tymlos |
| Paratek Pharmaceuticals, INC. | $23.71 | 2023 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $23.04 | 2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $21.98 | 2024 | |
| Sanofi Pasteur INC. | $21.78 | 2023 | |
| Idorsia Pharmaceuticals US INC | $21.50 | 2023 | Quviviq |
| Azurity Pharmaceuticals, INC. | $21.44 | 2025 | |
| Hikma Pharmaceuticals USA | $21.13 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $19.08 | 2024 | Crysvita |
| Inspire Medical Systems, INC. | $18.99 | 2025 | Inspire |
| Depuy Synthes Sales INC. | $18.32 | 2021 | |
| Fidia Pharma USA INC. | $18.12 | 2023 | Hymovis, Triluron |
| Vivus LLC | $15.88 | 2025 | Pancreaze |
| Evoke Pharma, INC. | $15.42 | 2022 | |
| Edwards Lifesciences Corporation | $15.15 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Smith+Nephew, INC. | $14.83 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abby Mcmahon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.